Regulation of cellular caveolin-1 protein expression in murine macrophages by microbial products

Infection and Immunity

Volumn 73, Issue 12, 2005, Pages 8136-8143

  Lei, Mei G ^a,b   Tan, Xiaoyu ^a   Qureshi, Nilofer ^a   Morrison, David C ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CAVEOLIN 1; LACTACYSTIN; LIPID A; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PACLITAXEL; PEPTIDOGLYCAN POLYSACCHARIDE; PROTEASOME; PROTEASOME INHIBITOR; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOCRINE EFFECT; BACTERIAL INFECTION; ENZYME INHIBITION; ESCHERICHIA COLI; FEMALE; LIPID RAFT; MOUSE; MOUSE STRAIN; NONHUMAN; PARACRINE SIGNALING; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; RHODOBACTER SPHAEROIDES; STAPHYLOCOCCUS AUREUS; UPREGULATION;

ANIMALS; CAVEOLIN 1; ESCHERICHIA COLI; FEMALE; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED STRAINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEASOME ENDOPEPTIDASE COMPLEX; RECOMBINANT PROTEINS; RHODOBACTER SPHAEROIDES; STAPHYLOCOCCUS AUREUS; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 28444470497     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.12.8136-8143.2005     Document Type: Article

References (40)

1. Alexander, C., and E. T. Rietschel. 2001. Bacterial lipopolysaccharides and innate immunity. J. Endotoxin Res. 7:167-202.
2. Amura, C. R., L.-C. Chen, N. Hirohashi, M. G. Lei, and D. C. Morrison. 1997. Two functionally independent pathways for lipopolysaccharide-dependent activation of mouse peritoneal macrophages. J. Immunol. 159:5079-5083.
3. Bucci, M., J.-P. Gratton, R. D. Rudic, L. Acevedo, F. Roviezzo, G, Cirino, and W. Sessa. 2000. In vivo delivery of the caveolin-1 scaSolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat. Med. 6:1362-1367.
4. Cooper, H. M., and Y. Paterson. 2000, Purification of immunoglobulin G fraction from antiserum, ascites fluid, or hybridoma supernatant, p. 11.14.1-11.14.5. In F. M. Ausubel, R. E. Kingston, J. G. Seidman, K. Struhl, D. D. Moore, R. Brent, and J. A. Smith (ed.), Current protocols in molecular biology. John Wiley and Sons, Inc., New York, N.Y.
5. Couet, J., S. Li, T. Okamoto, T. Ikezu, and M. P. Lisanti. 1997. Identification of peptide and protein ligands for the caveolin-scaffolding domain. J. Biol. Chem. 72:6525-6533.
6. Couet, J., M. Sargiacomo, and M. P. Lisanti. 1997. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J. Biol. Chem. 272: 30429-30438.
7. Das, K., R. Y. Lewis, P. E. Scherer, and M. P. Lisanti. 1999. The membrane-spanning domains of caveolins-1 and -2 mediate the formation of caveolin hetero-oligomers. J. Biol. Chem. 274:18721-18728.
8. Ding, A. H., F. Porteu, E. Sanchez, and C. F. Nathan. 1990. Shared actions of endotoxin and taxol on TNF receptors and TNF release. Science 248:370-372.
9. Feng, X., M. L. Gaeta, L. A. Madge, J. H. Yang, J. R. Bradley, and J. S. Pober. 2001. Caveolin-1 associates with TRAF2 to form a complex that is recruited to tumor necrosis factor receptors. J. Biol. Chem. 276:8341-8349.
10. Fenteany, G., and S. L. Schreiber. 1998. Lactacystin, proteasome function, and cell fate. J. Biol. Chem. 273:8545-8548.
11. Feron, O., C. Dessy, S. Moniotte, J.-P. Desager, and J. L. Balligand. 1999. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J. Clin. Investig. 103:897-905.
12. Glenney, J. R., Jr., and D. Soppet. 1992. Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts. Proc. Natl. Acad. Sci. USA 89:10517-10521.
13. Heinzel, F. P. 1990. The role of IFN-gamma in the pathology of experimental endotoxemia. J. Immunol. 145:2920-2924.
14. Henricson, B. E., P. Y. Perera, N. Qureshi, K. Takayama, and S. N. Vogel. 1992. Rhodopseudomonas sphaeroiaes lipid A derivatives block in vitro induction of tumor necrosis factor and endotoxin tolerance by smooth lipopolysaccharide and monophosphoryl lipid A. Infect. Immun. 60:4285-4290.
15. Hoffmann, J. A., F. C. Kafatos, C. A. Janeway, and R. A. Ezekowitz. 1999. Phylogenetic perspectives in innate immunity. Science 284:1313-1318.
16. Jacobs, D. M., and D. C. Morrison. 1977. Inhibition of the mitogenic response to lipopolysaccharide (LPS) in mouse spleen cells by polymyxin B. J. Immunol. 118:21-27.
17. Kirikae, T., F. D. Schade, F. Kirikae, N. Qureshi, K. Takayama, and E. T. Reitschel. 1994. Diphosphoryllipid A derived from the lipopolysaccharide (LPS) of Rhodobacter sphaeroides ATCC 17023 is a potent competitive LPS inhibitor in murine macrophage-like 1774 cells. FEMS Immunol. Med. Microbiol. 9:237-243.
18. Lei, M. G., and D. C. Morrison. 2000. Differential expression of caveolin-1 in lipopolysaccharide-activated murine macrophages. Infect. Immun. 68:5084-5089.
19. McIntire, F. C., H. W. Sievert, G. H. Barlow, R. A. Finley, and A. Y. Lee. 1967. Chemical, physical, and biological properties of a lipopolysaccharide from Escherichia coli K-235. Biochemistry 6:2363-2372.
20. Morrison, D. C., and R. J. Curry. 1979. The use of polymyxin B and C3H/ HeJ mouse spleen cells as criteria for endotoxin contamination. J. Immunol. Methods 10:83-92.
21. Morrison, D. C., and J. L. Ryan. 1987. Endotoxins and disease mechanisms. Annu. Rev. Med. 38:417-432.
22. Okamato, T., A. Schlegel, P. E. Scherer, and M. P. Lisanti. 1998. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J. Biol. Chem. 273:5419-5422.
23. Perera, P. Y., T. N. Mayadas, O. Takeuchi, S. Akira, M. Zaks-Zilberman, S. M. Goyert, and S. N. Vogel. 2001. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression. J. Immunol. 166:574-581.
24. Qureshi, N., B. Jarvis, and K. Takayama. 1999. Nontoxic RsDPLA as a potent antagonist of toxic lipopolysaccharide, p. 687-698. In H. Brade, S. M. Opal, S. N. Vogel, and D. C. Morrison (ed.), Endotoxin in health and disease. Marcel Dekker, New York, N.Y.
25. Qureshi, N., P. Y. Perera, J. Shen, G. Zhang, A. Lenschat, G. Splitter, D. C. Morrison, and S. N. Vogel. 2003. The proteasome as a lipopolysaccharide- binding protein in macrophages: differential effects of proteasome inhibition on lipopolysaccharide-induced signaling events. J. Immunol. 171:1515-1525.
26. Qureshi, N., K. Takayama, and R. Kurtz. 1991. Diphosphoryl lipid A from the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides is an endotoxin antagonist in mice. Infect. Immun. 59:441-444.
27. Qureshi, N., K. Takayama, P. Mascagni, J. Honowich, R. Wang, and R. J. Cotter. 1988. Complete structural determination of lipopolysaccharides obtained from deep rough mutant of Escherichia coli: purification by high performance liquid chromatography and direct analysis by plasma desorption mass spectrometry. J. Biol. Chem. 263:11971-11976.
28. Qureshi, N., K. Takayama, K. C. Meyer, T. N. Kirkland, C. A. Bush, L. Chen, R. Wang, and R. J. Cotter. 1991. Chemical reduction of 3-oxo and unsaturated groups in fatty acids of diphosphoryl lipid A from the lipopolysaccharide of Rhodopseudomonas sphaeroides: comparison of biological properties before and after reduction. J. Biol. Chem. 266:6532-6538.
29. Rothberg, K. G., J. E. Houser, W. C. Donzell, Y.-S. Ying, J. R. Glenney, and R. G. W. Anderson. 1992. Caveolin, a protein component of caveolae membrane coats. Cell 68:673-682.
30. Sargiacomo, M., P. R. Scherer, Z. L. Tang, E. Kübler, K. S. Song, M. C. Sanders, and M. P. Lisanti. 1995. Oligomeric structure of caveolin: implications for caveolae membrane organization. Proc. Natl. Acad. Sci. USA 92:9407-9411.
31. Schubert, A. L., W. Schubert, D. C. Spray, and M. P. Lisanti. 2002. Connexin family members target to lipid raft domains and interact with caveolin-1. Biochemistry 41:5754-5764.
32. Shaul, P. W., and R. G. W. Andersen. 1998. Role of plasmalemmal caveolae in signal transduction. Am. J. Physiol. 275:L843-L851.
33. Shimazu, R., S. Akashi, H. Ogata, Y. Nagai, K. Fukudome, K. Miyake, and M. Kimoto. 1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189:1777-1782.
34. Smart, R. J., G, A. Graf, M. A. McNiven, W. C. Sessa, J. A. Engelman, P. E. Scherer, T. Okamoto, and M. P. Lisanti. 1999. Caveolins, liquid-ordered domains, and signal transduction. Mol. Cell. Biol. 19:7289-7304.
35. Song, K. S., Z. L. Tang, S. Li, and M. P. Lisanti. 1997. Mutational analysis of the properties of caveolin-1. J. Biol. Chem. 272:4398-4403.
36. Takayama, K., N. Qureshi, R. Beutler, and T. N. Kirkland. 1989. The diphosphoryllipid A from Rhodopseudomonas sphaeroides ATCC 17023 blocks induction of cachectin in macrophages by lipopolysaccharide. Infect. Immun. 57:1335-1339.
37. Tang, Z., T. Okamoto, P. Boontrakulpoontawee, T. Katada, A. J. Otsuka, and M. P. Lisanti. 1997. Identification, sequence, and expression of an invertebrate caveolin gene family from the nematode Caenorhabditis elegans. Implications for the molecular evolution of mammalian caveolin genes. J. Biol. Chem. 272:2437-2445.
38. Visintin, A., E. Latz, B. G. Monks, T. Espevik, and D. T. Golenbock. 2003. Lysines 128 and 132 enable lipopolysaccharide binding to MD-2, leading to Toll-like receptor-4 aggregation and signal transduction. J. Biol. Chem. 278: 48313-48320.
39. Weisz, A., S. Oguchi, L. Cicatiello, and H. Esumi. 1994. Dual mechanism for the control of inducible-type NO synthase gene expression in macrophages during activation by interferon-gamma and bacterial lipopolysaccharide. Transcriptional and post-transcriptional regulation. J. Biol. Chem. 269:8324-8333.
40. Zhang, X., and D. C. Morrison. 1993. Lipopolysaccharide-induced selective priming effects on tumor necrosis factor alpha and nitric oxide production in mouse peritoneal macrophages. J. Exp. Med. 177:511-516.